Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
10/14/1993 | WO1993019785A1 Recombinant human hiv-neutralizing monoclonal antibodies for prevention and treatment of hiv infection |
10/14/1993 | WO1993019782A1 Specific detection of cell surface receptor leukocyte adhesion molecule-1 |
10/14/1993 | WO1993019777A1 Fusion proteins comprising tumor necrosis factor receptor |
10/14/1993 | WO1993019768A1 Self-assembling polynucleotide delivery system |
10/14/1993 | WO1993019767A1 Cd28 pathway immunoregulation |
10/14/1993 | WO1993019660A1 Gene therapy using the intestine |
10/14/1993 | WO1993019605A1 Evaluation and treatment of patients with progressive immunosuppression |
10/14/1993 | WO1993019603A1 Prokaryotes including dna encoding bacteriophage immunity |
10/14/1993 | WO1993019591A1 Methods and compositions for gene, tumor, and viral infection therapy, and prevention of programmed cell death (apoptosis) |
10/14/1993 | WO1993019585A1 Induction of somatic embryogenesis in taxus, and the production of taxane-ring containing alkaloids therefrom |
10/14/1993 | WO1993017118A3 Defective packaging non-oncoviral vectors based on mpmv and hiv |
10/14/1993 | WO1993017110A3 A recombinant hepatitis c virus polypeptide |
10/14/1993 | WO1993014208A3 Hepatitis e virus vaccine and method |
10/14/1993 | WO1992008456A3 Method of inhibiting transformation, growth and metastasis of cells in which purine metabolic enzyme activity is elevated |
10/14/1993 | DE4211517A1 Verfahren zur Herstellung rekombinanter Proteine in Streptomyceten A process for the production of recombinant proteins in streptomycetes |
10/14/1993 | CA2133662A1 Antibodies for treatment and prevention of respiratory syncytial virus infection |
10/14/1993 | CA2133643A1 Method and device for detection of nucleic acid or analyte using total internal reflectance |
10/14/1993 | CA2133481A1 Methods for inactivating nucleotide sequences and metal chelates for use therein |
10/14/1993 | CA2133443A1 Cloning, expression and uses of a novel secreted protein, f-spondin |
10/14/1993 | CA2133411A1 Gene therapy using targeted viral vectors |
10/14/1993 | CA2133220A1 Method of multiplex ligase chain reaction |
10/14/1993 | CA2133075A1 CD28 Pathway Immunoregulation |
10/14/1993 | CA2132961A1 Genetic sequences encoding flavonoid pathway enzymes and uses therefor |
10/14/1993 | CA2132949A1 Stability-enhanced variants of parathyroid hormone |
10/14/1993 | CA2132859A1 Decorin fragments and methods of inhibiting cell regulatory factors |
10/14/1993 | CA2132624A1 Compositions and methods for regulating cellular signal transducing systems |
10/14/1993 | CA2132434A1 Endo-.beta.-1, 4-glucanase and a dna sequence |
10/14/1993 | CA2132433A1 A novel enzyme and a dna sequence |
10/14/1993 | CA2132335A1 Delignifying preparation exhibiting .alpha.-l-arabinofuranosidase activity production and application thereof |
10/14/1993 | CA2131994A1 Synthesis of oligonucleotides |
10/14/1993 | CA2131532A1 Induction of somatic embryogenesis in taxus, and the production of taxane-ring containing alkaloids therefrom |
10/14/1993 | CA2128203A1 Immunoassay for detecting hcv igm antibody |
10/14/1993 | CA2117884A1 Non-infectious hiv particles and uses therefor |
10/14/1993 | CA2117603A1 Method of sequencing |
10/14/1993 | CA2110295A1 Anti-hbs antibody genes and expression plasmids therefor |
10/13/1993 | EP0565370A1 Serotonin receptor protein and related DNA compounds |
10/13/1993 | EP0565208A1 DNA fragment encoding OspA of Borrelia burgdorferi, vaccine and diagnostics comprising OspA encoded by the DNA fragment |
10/13/1993 | EP0565172A1 Cloning and expression of DNA encoding a ripening form of a polypeptide having sulfhydryl oxidase activity |
10/13/1993 | EP0565164A1 Synthetic polypeptides as inhibitors of HIV-1 |
10/13/1993 | EP0564965A2 Integrative gene-expression in food-grade microorganisms |
10/13/1993 | EP0564801A1 Analysis of host cell shut-off |
10/13/1993 | EP0564645A1 Transformant cells for the prophylaxis or treatment of diseases caused by viruses, particularly pathogenic retroviruses |
10/13/1993 | EP0564595A1 Stable transformation of maize cells by electroporation. |
10/13/1993 | EP0564592A1 Liver enriched transcription factor |
10/13/1993 | EP0564539A1 Sustained and continuous production of high titers of recombinant viral vectors and transduced target cells for use in gene therapy |
10/13/1993 | EP0564532A1 Polypeptides derived from proteins of the hepatitis c virus |
10/13/1993 | EP0564531A1 Enrichment method for variant proteins with altered binding properties |
10/13/1993 | EP0564524A1 Control of fruit ripening and senescence in plants |
10/13/1993 | EP0564513A1 TAPETUM-SPECIFIC PROMOTERS FROM $i(BRASSICACEAE) SPP |
10/13/1993 | EP0540687A4 Antibody-mediated cofactor-driven reactions |
10/13/1993 | EP0318487B1 Serum free tissue culture medium containing polymeric cell-protective agent |
10/13/1993 | CN1077224A A process for expressing polypeptide |
10/12/1993 | US5252726 Derived from Aspergillus niger neutral alpha-amylase gene |
10/12/1993 | US5252724 Digestion; reacting linkers with fragments; hybridization; isolation |
10/12/1993 | US5252708 Preparation process for a protein containing at least one intramolecular disulphide bridge by oxidation, at a pH of less than 5.0 of corresponding reduced recombinant protein |
10/12/1993 | US5252482 Precursor of a C-terminal amidated calcitonin |
10/12/1993 | US5252480 Human monoclonal antibody and hybridoma producing the same |
10/12/1993 | US5252479 Safe vector for gene therapy |
10/12/1993 | US5252478 Thermostable mutants of neutral protease and means for their preparation |
10/12/1993 | US5252477 Human immunodeficiency virus specific proteolytic enzyme and a method for its synthesis and renaturation |
10/12/1993 | US5252476 Superoxide dismutase cloning and expression in microorganisms |
10/12/1993 | US5252475 Methods and vectors for selectively cloning exons |
10/12/1993 | US5252474 Cloning genes from Streptomyces avermitilis for avermectin biosynthesis and the methods for their use |
10/12/1993 | US5252466 Fusion proteins having a site for in vivo post-translation modification and methods of making and purifying them |
10/12/1993 | US5252465 Avian erythroblastosis virus vectors for integration and expression of heterologous genes in avian cells |
10/12/1993 | US5252289 Water soluble 1,2-dithio-3-thiones |
10/12/1993 | CA1322942C Method of gene mapping |
10/11/1993 | CA2093575A1 Human antithrombin iii mutant |
10/10/1993 | CA2093506A1 Serotonin receptor protein and related dna compounds |
10/08/1993 | CA2093498A1 Complete gene (cefg) encoding the acetyl-coa: deacetylcephalosporin c acetyltransferase of cephalosporium acremonium, its isolation and use |
10/08/1993 | CA2093495A1 Angiotensin ii type-1 receptor and its production |
10/07/1993 | DE4222407C1 Modulartiges Promotor-Konstrukt A modular promoter construct |
10/06/1993 | EP0563714A2 TNF-Muteins |
10/06/1993 | EP0563527A1 Process for the detection of insertion elements or transposons |
10/06/1993 | EP0563487A1 Monoclonal antibodies against the interferon receptor, with neutralizing activity against type I interferon |
10/06/1993 | EP0563323A1 Hiv reverse transcriptase vaccine |
10/06/1993 | EP0563311A1 Improved vaccines |
10/06/1993 | EP0563302A1 Method and apparatus for granulation |
10/06/1993 | EP0563296A1 Optimization of binding proteins |
10/06/1993 | EP0563278A1 Control of gene expression by ionizing radiation |
10/06/1993 | EP0563244A1 Human phospholipase activating protein and methods for diagnosis of rheumatoid arthritis |
10/06/1993 | EP0563240A1 Lipid receptors for microorganisms and corresponding adhesins, dna sequences encoding adhesins, and use thereof |
10/06/1993 | EP0563239A1 A truncated interleukin-1 receptor gene for the treatment of arthritis |
10/06/1993 | EP0563201A1 Genetically engineered modification of potato to form amylose-type starch |
10/06/1993 | EP0563200A1 DNA SEQUENCES ENCODING AT LEAST PART OF THE TOMATO ENZYME ENDOPOLYGALACTURONASE PG1 $g(b)-SUBUNIT |
10/06/1993 | EP0563198A1 TARGETTING IgE EFFECTOR CELLS TO TUMOR CELLS |
10/06/1993 | EP0563191A1 Nucleotide sequences of soybean acyl-acp thioesterase genes. |
10/06/1993 | EP0563189A1 Genetically engineered modification of potato to form amylopectin-type starch |
10/06/1993 | EP0563175A1 A method of constructing synthetic leader sequences |
10/06/1993 | EP0563172A1 Synthetic bioadhesive polypeptide |
10/06/1993 | EP0563161A1 Plant dna |
10/06/1993 | EP0563157A1 Dna, dna constructs, cells and plants derived therefrom |
10/06/1993 | EP0563103A1 Enzymes and enzymatic detergent compositions |
10/06/1993 | EP0563093A1 A composition used as a therapeutic agent against chronic viral hepatic diseases |
10/06/1993 | EP0563089A1 Serotonine receptor of class 1: the 5-ht 1x? receptors |
10/06/1993 | EP0556345A4 Retroviral vectors useful for gene therapy |
10/06/1993 | EP0454778A4 Molecules with antibody combining sites that exhibit stereospecific catalysis |
10/06/1993 | EP0429497B1 Cocumber mosaic virus coat protein gene |
10/06/1993 | CN1076966A Cloning and expression of humanized monoclonal antibodies against human interleukin-4 |
10/06/1993 | CN1076965A Novel fungal strains and use thereof in antibiotic production |